Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1651, Issue 1-2, 2003, Pages 116-123

  Vargas, J D ^a   Herpers, B ^a   McKie, A T ^b   Gledhill, S ^c   McDonnell, J ^d   Van Den Heuvel, M ^a   Davies, K E ^a   Ponting, C P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Pentland House   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cytochrome b561; Ferric reductase; hpx; sdr2

Indexed keywords

CYTOCHROME; CYTOCHROME B; CYTOCHROME B561; IRON REGULATORY FACTOR; OXIDOREDUCTASE; RECEPTOR; STROMAL CELL DERIVED RECEPTOR 2; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CYBRD1 PROTEIN, HUMAN; CYBRD1 PROTEIN, MOUSE; FERRIC CITRATE IRON REDUCTASE; FLAVINE MONONUCLEOTIDE REDUCTASE; IRON; STROMAL CELL DERIVED RECEPTOR 2, MOUSE; STROMAL CELL-DERIVED RECEPTOR 2, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN VENTRICLE; CHOROID PLEXUS; CONTROLLED STUDY; DUODENUM; ENZYME ACTIVITY; EPENDYMA CELL; FEMALE; FLY; IN SITU HYBRIDIZATION; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION; ANIMAL; BRAIN; C57BL MOUSE; CYTOLOGY; GENETICS; HUMAN; METABOLISM; MULTIGENE FAMILY; OOCYTE; PHYSIOLOGY; TRANSGENIC MOUSE; XENOPUS LAEVIS;

CELLULAR ORGANISMS;

ANIMALS; BRAIN; CYTOCHROME B GROUP; FEMALE; FMN REDUCTASE; HUMANS; IN SITU HYBRIDIZATION; IRON; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIGENE FAMILY; OOCYTES; OXIDOREDUCTASES; RATS; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION; XENOPUS LAEVIS;

EID: 0642341947     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(03)00242-5     Document Type: Article

References (43)

1. Thompson K.J., Shoham S., Connor J.R. Iron and neurodegenerative disorders. Brain Res. Bull. 55:2001;155-164.
2. Walter T. Impact of iron deficiency on cognition in infancy and childhood. Eur. J. Clin. Nutr. 47:1993;307-316.
3. Pollitt E. Iron deficiency and cognitive function. Annu. Rev. Nutr. 13:1993;521-537.
4. Lozoff B., Brittenham G.M. Behavioral aspects of iron deficiency. Prog. Hematol. 14:1986;23-53.
5. Earley C.J., Allen R.P., Beard J.L., Connor J.R. Insight into the pathophysiology of restless legs syndrome. J. Neurosci. Res. 62:2000;623-628.
6. van der Knaap M.S., Valk J. The reflection of histology in MR imaging of Pelizaeus-Merzbacher disease. AJNR, Am. J. Neuroradiol. 10:1989;99-103.
7. Hirsch E.C., Faucheux B.A. Iron metabolism and Parkinson's disease. Mov. Disord. 13:1998;39-45.
8. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
9. Youdim M.B., Ben-Shachar D., Riederer P. The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8:1993;1-12.
10. Aisen P., Enns C., Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell Biol. 33:2001;940-959.
11. Floyd R.A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4:1990;2587-2597.
12. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
13. Linert W., Herlinger E., Jameson R.F., Kienzl E., Jellinger K., Youdim M.B. Dopamine, 6-hydroxydopamine, iron, and dioxygen-their mutual interactions and possible implication in the development of Parkinson's disease. Biochim. Biophys. Acta. 1316:1996;160-168.
14. Owen A.D., Schapira A.H., Jenner P., Marsden C.D. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies. J. Neural Transm., Suppl. 51:1997;167-173.
15. Curtis A.R., Fey C., Morris C.M., Bindoff L.A., Ince P.G., Chinnery P.F., Coulthard A., Jackson M.J., Jackson A.P., McHale D.P., Hay D., Barker W.A., Markham A.F., Bates D., Curtis A., Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 28:2001;350-354.
16. LaVaute T., Smith S., Cooperman S., Iwai K., Land W., Meyron-Holtz E., Drake S.K., Miller G., Abu-Asab M., Tsokos M., Switzer R. III, Grinberg A., Love P., Tresser N., Rouault T.A. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27:2001;209-214.
17. Moos T., Morgan E.H. Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20:2000;77-95.
18. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
19. Fleming M.D., Trenor C.C. III, Su M.A., Foernzler D., Beier D.R., Dietrich W.F., Andrews N.C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16:1997;383-386.
20. McKie A.T., Barrow D., Latunde-Dada G.O., Rolfs A., Sager G., Mudaly E., Mudaly M., Richardson C., Barlow D., Bomford A., Peters T.J., Raja K.B., Shirali S., Hediger M.A., Farzaneh F., Simpson R.J. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science. 291:2001;1755-1759.
21. Flatmark T., Terland O. Cytochrome b561 of the bovine adrenal chromaffin granules. A high potential b-type cytochrome. Biochim. Biophys. Acta. 253:1971;487-491.
22. Ponting C.P. Domain homologues of dopamine beta-hydroxylase and ferric reductase: roles for iron metabolism in neurodegenerative disorders? Hum. Mol. Genet. 10:2001;1853-1858.
23. Shirozu M., Tada H., Tashiro K., Nakamura T., Lopez N.D., Nazarea M., Hamada T., Sato T., Nakano T., Honjo T. Characterization of novel secreted and membrane proteins isolated by the signal sequence trap method. Genomics. 37:1996;273-280.
24. Simpson R.J., Lombard M., Raja K.B., Thatcher R., Peters T.J. Iron absorption by hypotransferrinaemic mice. Br. J. Haematol. 78:1991;565-570.
25. Bernstein S.E. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J. Lab. Clin. Med. 110:1987;690-705.
26. Iancu T.C., Shiloh H., Raja K.B., Simpson R.J., Peters T.J., Perl D.P., Hsu A., Good P.F. The hypotransferrinaemic mouse: ultrastructural and laser microprobe analysis observations. J. Pathol. 177:1995;83-94.
27. Takeda A., Takatsuka K., Connor J.R., Oku N. Abnormal iron accumulation in the brain of neonatal hypotransferrinemic mice. Brain Res. 912:2001;154-161.
28. Dickinson T.K., Connor J.R. Cellular distribution of iron, transferrin, and ferritin in the hypotransferrinemic (Hp) mouse brain. J. Comp. Neurol. 355:1995;67-80.
29. Malecki E.A., Cook B.M., Devenyi A.G., Beard J.L., Connor J.R. Transferrin is required for normal distribution of 59 Fe and 54 Mn in mouse brain. J. Neurol. Sci. 170:1999;112-118.
30. Raymond V., Mongan N.P., Sattelle D.B. Anthelmintic actions on homomer-forming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans. Neuroscience. 101:2000;785-791.
31. Huggenvik J.I., Craven C.M., Idzerda R.L., Bernstein S., Kaplan J., McKnight G.S. A splicing defect in the mouse transferrin gene leads to congenital atransferrinemia. Blood. 74:1989;482-486.
32. Sigel E. Properties of single sodium channels translated by Xenopus oocytes after injection with messenger ribonucleic acid. J. Physiol. 386:1987;73-90.
33. Sigel E. Use of Xenopus oocytes for the functional expression of plasma membrane proteins. J. Membr. Biol. 117:1990;201-221.
34. Wagner C.A., Friedrich B., Setiawan I., Lang F., Broer S. The use of Xenopus laevis oocytes for the functional characterization of heterologously expressed membrane proteins. Cell Physiol. Biochem. 10:2000;1-12.
35. Wakefield L.M., Cass A.E., Radda G.K. Functional coupling between enzymes of the chromaffin granule membrane. J. Biol. Chem. 261:1986;9739-9745.
36. Menniti F.S., Knoth J., Diliberto E.J. Jr. Role of ascorbic acid in dopamine beta-hydroxylation. The endogenous enzyme cofactor and putative electron donor for cofactor regeneration. J. Biol. Chem. 261:1986;16901-16908.
37. Bharath S., Hsu M., Kaur D., Rajagopalan S., Andersen J. Glutathione, iron and Parkinson's disease. Biochem. Pharmacol. 64:2002;1037-1048.
38. Muir A., Hopfer U. Regional specificity of iron uptake by small intestinal brush-border membranes from normal and iron-deficient mice. Am. J. Physiol. 248:1985;G376-G379.
39. Bacon B.R., Tavill A.S. Role of the liver in normal iron metabolism. Semin. Liver Dis. 4:1984;181-192.
40. Wareing M., Ferguson C.J., Green R., Riccardi D., Smith C.P. In vivo characterization of renal iron transport in the anaesthetized rat. J. Physiol. 524(Pt 2):2000;581-586.
41. Ferguson C.J., Wareing M., Ward D.T., Green R., Smith C.P., Riccardi D. Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am. J. Physiol., Renal. Physiol. 280:2001;F803-F814.
42. Sun I.L., Navas P., Crane F.L., Morre D.J., Low H. NADH diferric transferrin reductase in liver plasma membrane. J. Biol. Chem. 262:1987;15915-15921.
43. Fleming M.D., Romano M.A., Su M.A., Garrick L.M., Garrick M.D., Andrews N.C. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl. Acad. Sci. U. S. A. 95:1998;1148-1153.